Parasite Immunology
The nature of most parasites' ongoing interactions with the body causes a prodigious immune response. Sadly, a large portion of this response isn't protective, and a small portion is damaging. Because parasites are protein-coated, they are susceptible to direct toxicity by macrophages, eosinophils, and neutrophils in situations when protective immunity is provided by a combination of bodily material and cellular protection. One infection can be warded off by protein alone. While non-specific and genetic variables are undoubtedly important, they are still ill-defined participants in the host response. By inducing hypersensitivity, disease that is mediated by immunology, or existing immune complexes, the immune system also responds in a harmful way. Additionally, parasites have developed unique defence mechanisms against the immune system, including the ability to modify their substance coat and cause immunological disorders. The development of efficient immunising agents may emerge from attempts to extract "host-protective" antigens in parasite diseases.
Related Conference of Parasite Immunology
21th International Conference on Allergic Diseases and Clinical Immunology
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Parasite Immunology Conference Speakers
Recommended Sessions
- Cancer Immunology and Immunotherapy
- Cell and developmental biology
- Cellular and molecular immunology
- Diagnostic and Technological novelty of Immunology
- Epidemiology
- Immune System
- Immunodeficiency
- Immunogenetics
- Immunoinformatics & Systemsimmunology
- Immunological techniques
- Immunology
- Immunopathology
- Immunotherapy
- Immunotoxicology
- Neuroimmunology
- Parasite Immunology
- Pediatrics Immunology
- Plant cell biology
- Reproductive Immunology
- Transplantation Immunology
- Vaccines and Vaccination
- Viral Immunology
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Infectious Diseases - Antibiotics 2026 (UK)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)

